title: Microbladder after the BCG therapy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Ballestero Diego
authors.forename: Sergio
authors.initials: S
authors.lastname: Zubillaga Guerrero
authors.forename: Pedro Lastra
authors.initials: PL
authors.lastname: García-Barón
authors.forename: David
authors.initials: D
authors.lastname: Truán Cacho
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Portillo Martín
authors.forename: José Ignacio
authors.initials: JI
authors.lastname: del Valle Schaan
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Correas Gómez
authors.forename: Emma
authors.initials: E
authors.lastname: Hidalgo Zabala
authors.forename: Felix
authors.initials: F
authors.lastname: Campos Juanatey
authors.forename: Lucía
authors.initials: L
authors.lastname: Gala Solana
authors.forename: Enrique
authors.initials: E
authors.lastname: Mediavilla Díez
authors.forename: Javier
authors.initials: J
authors.lastname: Fuentes Pastor
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D001745:Urinary Bladder Diseases / Q000139:chemically induced*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine